Update and critical appraisal of the use of topical azithromycin ophthalmic 1% (AzaSite®) solution in the treatment of ocular infections
Canan Asli UtineYeditepe University, Department of Ophthalmology, Istanbul, Turkey and Ocular Surface Disease and Dry Eye Clinic, Cornea and External Disease Service, The Wilmer Eye Institute, The Johns Hopkins University School of Medicine, Baltimore, MD, USAAbstract: Azithromycin is an azalide tha...
Enregistré dans:
Auteur principal: | Utine CA |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2011
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/a993340aa4c94f4084a85d2aeaaa5a9c |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Azithromycin in DuraSite® for the treatment of blepharitis
par: Jodi Luchs
Publié: (2010) -
Intracorneal ring implantation using Intralase® with partial coverage of the cone in a patient after an alkaline injury
par: Cakir H, et autres
Publié: (2011) -
Topical azithromycin or ofloxacin for endophthalmitis
par: Stewart ML, et autres
Publié: (2012) -
PERSIST: Physician's Evaluation of Restasis® Satisfaction in Second Trial of topical cyclosporine ophthalmic emulsion 0.05% for dry eye: a retrospective review
par: Mah F, et autres
Publié: (2012) -
Fluoroquinolones compared to 1% azithromycin in DuraSite® for bacterial conjunctivitis [from Lichenstein and Granet] and Response to correspondence [from Friedlaender and Protzko] ||FREE PAPER||
par: Steven J Lichtenstein, et autres
Publié: (2008)